CLU and urinary bladder carcinoma: Several studies have used MRM to obtain detailed expression profiles of sEV proteins and to identify potential biomarkers such as HSP90 and syndecan-1 in bladder cancer, and annexin A2 and clusterin in Alzheimer's disease [139–141].